Subject
Genetics,General Medicine
Reference24 articles.
1. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature;Adnane;Methods Enzymol.,2006
2. Tumorigenesis and the angiogenic switch;Bergers;Nat. Rev. Cancer,2003
3. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells;Chinchar;Vasc. Cell,2014
4. VEGFA and tumour angiogenesis;Claesson-Welsh;J. Intern. Med.,2013
5. Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironment;Epstein Shochet;Lung Cancer,2016
Cited by
284 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献